Vietnam.vn - Nền tảng quảng bá Việt Nam

Improving the quality of management and treatment of hereditary cancer

In order to improve the quality of treatment and care for cancer patients, especially those with genetic factors, AstraZeneca Vietnam has accompanied domestic hospitals and frontline training facilities to carry out many scientific activities in June.

Báo Thanh niênBáo Thanh niên26/06/2025

Activities carried out: conference "Cancer Genetics"; scientific seminars; intensive extracurricular training on genetic counseling... Many leading experts with updated reports and more than 800 domestic doctors, medical staff ; foreign experts attended.

Cancer is one of the leading causes of death worldwide. In addition to environmental risk factors, certain genetic mutations can be passed down through generations in families, increasing the risk of cancer. People who have been identified as carriers of cancer-associated genetic mutations should be managed, screened according to a separate program, and counseled on risk-reducing interventions.

In addition, some hereditary cancers can be effectively treated with appropriate targeted therapies. Cancers that have been identified as being associated with inherited gene mutations, the most common of which is the BRCA1/2 gene, are diseases with increasing incidence and mortality rates each year.

Improving the quality of hereditary cancer management in Vietnam with AstraZeneca - Photo 1.

Extracurricular training is part of a series of events organized by AstraZeneca Vietnam in June.

PHOTO: DVCC

According to data from the Global Cancer Registry (GLOBOCAN 2022), each year in Vietnam there are: breast cancer: 24,563 new cases, 10,008 deaths; ovarian cancer: 1,534 new cases, 1,003 deaths; prostate cancer: 5,875 new cases, 2,800 deaths; pancreatic cancer: 1,251 new cases, 1,226 deaths.

The rate of carrying genetic mutations (also known as germline mutations) BRCA1/2 in cancer diseases recorded in medical literature is: ovarian carcinoma (about 15%), triple-negative breast cancer (10 - 17%), hormone receptor-positive breast cancer (6%), prostate cancer (5 - 10%), pancreatic carcinoma (5 - 7%).

This situation requires that management and improvement of the quality of diagnosis and treatment of hereditary cancer be promoted and prioritized more in the coming time, in order to detect the disease, intervene promptly, and treat effectively.

Source: https://thanhnien.vn/nang-cao-chat-luong-quan-ly-dieu-tri-ung-thu-di-truyen-18525062519003822.htm


Comment (0)

No data
No data

Same tag

Same category

DIFF 2025 - An explosive boost for Da Nang's summer tourism season
Follow the sun
The majestic cave arc in Tu Lan
The plateau 300km from Hanoi has a sea of ​​clouds, waterfalls, and bustling visitors.

Same author

Heritage

Figure

Enterprise

No videos available

News

Political System

Destination

Product